Ladias, Nhorhannie .

HRN: 22-82-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/06/2023
IV
1.5 G
1.5 Grams
For Pelvic Lap For Ectopic Pregnancy
Waiting Final Action 
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/06/2023
IV
1.5 G
1.5 Grams
For Pelvic Lap For Ectopic Pregnancy
Waiting Final Action 
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/06/2023
IV
1.5 G
1.5 Grams
For Pelvic Lap For Ectopic Pregnancy
Waiting Final Action 
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/06/2023
IV
1.5 G
1.5 Grams
For Pelvic Lap For Ectopic Pregnancy
Waiting Final Action 
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/06/2023
IV
1.5 G
1.5 Grams
For Pelvic Lap For Ectopic Pregnancy
Waiting Final Action 
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/07/2023
IV
1.5grams
Every 8 Hours For 3 Doses
S/P Pelvic Lap
Waiting Final Action 
04/06/2023
CEFUROXIME 500MG (TAB)
04/07/2023
04/14/2023
PER OREM
500 Mg
Twice A Day
S/P Pelvic Lap
Waiting Final Action 
04/07/2023
DOXYCYCLINE 100MG (CAP)
04/07/2023
04/14/2023
PO
100 Mg
Every 12 Hours
S/P Pelvic Lap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: